Sunday 18 October 2026
Export APMD’s income statement to Excel — free account
Apnimed, Inc.
APMD
Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.
17.76
0.49
−2.68%
Follow APMD
| Dec '24 | Dec '25 | |
|---|---|---|
P/E ratio |
1.27 | 1.27 |
P/S ratio |
1.02 | 1.02 |
Altman Z″-Score (non-manufacturers) |
(13.94) | (29.54) |
P/FCF ratio |
0.00 | 0.00 |
Beneish M-Score |
— | 0.00 |
P/Operating CF |
(6.62) | (6.62) |
P/B ratio |
0.00 | 0.00 |
Price to Tangible BV |
0.00 | 0.00 |
EV/Sales |
0.23 | 0.23 |
EV/EBITDA |
1.15 | 1.15 |
EV/Operating CF |
(0.32) | (0.32) |
EV/FCF |
(0.32) | (0.32) |
Quick Ratio |
1.64 | 0.39 |
Current Ratio |
1.73 | 0.41 |
Net Debt/EBITDA |
0.60 | 0.02 |
Debt/Assets |
0.00% | 55.78% |
Debt/Equity |
0.00 | (0.11) |
Asset Turnover |
0.00 | 0.42 |
Operating CF/Net income |
0.99 | 0.61 |
Capex/Depreciation |
(3.04) | 0.00 |
| 0.00% | 41.26% | |
| 0.00% | (140.79%) | |
ROIC |
0.00% | 0.00% |
Return on Tangible Assets |
(359.28%) | 194.95% |
Average Days of Receivables |
50.80 | 9.10 |
Research and Development Expense of Revenue |
1,215.36% | 161.44% |
Selling, General and Administrative Expense of Revenue |
268.37% | 61.07% |
Intangible Assets out of Total Assets |
0.00 | 0.00 |
Share Based Compensation of Revenue |
37.84% | 10.16% |
Graham Net Nets |
(1.56) | (1.56) |
Graham Number |
0.00 | 0.00 |
Earnings Yield |
78.92% | 78.92% |
Free Cash Flow Yield |
(69.83%) | (69.83%) |
Revenue per Share |
1.69 | 8.08 |
Operating CF per Share |
(23.23) | (16.34) |
Capex per Share |
(0.01) | 0.00 |
Free Cash Flow per Share |
(23.25) | (16.34) |
Cash per Share |
14.41 | 8.79 |
Shareholders Equity per Share |
(52.41) | (78.27) |
Interest Debt per Share |
0.00 | 0.00 |
Book value per Share |
(52.41) | (78.27) |
Free Cash Flow |
(110.28) | (77.83) |
Working Capital |
30.89 | (65.82) |
Capital Expenditures |
(0.07) | — |
Net Current Asset Value |
(284.59) | (400.60) |
EV/EBIT |
1.15 | 1.15 |
Capex to Sales |
0.01 | 0.00 |
Price to Operating Income |
5.15 | 5.15 |
| Other line items | ||
Depreciation/Fixed assets |
0.25 | 0.41 |
Cash ROIC |
61.18% | 26.82% |
Accounts Receivable Turnover |
0.00 | 37.09 |
Accounts Payable Turnover |
0.00 | 2.49 |
Inventory Turnover |
0.00 | 0.00 |
Average Days of Payables |
388.40 | 97.49 |
Days of Inventory on Hand |
0.00 | 0.00 |
Average Receivables |
— | 1.04 |
Average Payables |
— | 2.69 |
Average Assets |
— | 91.05 |
Average Common Equity |
— | (310.70) |
Columns are period end dates · fundamentals updated 7 Oct 2026